Outcomes of heart transplantation from hepatitis C virus–positive donors

This publication has 24 references indexed in Scilit:

• Direct-acting antiviral agent efficacy and safety in renal transplant recipients with chronic hepatitis C virus infection
  Medicine, 2017
• The “PHS Increased Risk” Label Is Associated With Nonutilization of Hundreds of Organs per Year
  Transplantation, 2017
• Trial of Transplantation of HCV-Infected Kidneys into Uninfected Recipients
  New England Journal of Medicine, 2017
• The American Society of Transplantation Consensus Conference on the Use of Hepatitis C Viremic Donors in Solid Organ Transplantation
  American Journal of Transplantation, 2017
• Safety and efficacy of current direct‐acting antiviral regimens in kidney and liver transplant recipients with hepatitis C: Results from the HCV‐TARGET study
  Hepatology, 2017
• Oral Direct-Acting Agent Therapy for Hepatitis C Virus Infection
  Annals of Internal Medicine, 2017
• Relationship between Nonmedical Prescription-Opioid Use and Heroin Use
  New England Journal of Medicine, 2016
• Solid Organ Transplantation From Hepatitis B Virus–Positive Donors: Consensus Guidelines for Recipient Management
  American Journal of Transplantation, 2015
• The 2013 International Society for Heart and Lung Transplantation Working Formulation for the standardization of nomenclature in the pathologic diagnosis of antibody-mediated rejection in heart transplantation
  The Journal of Heart and Lung Transplantation, 2013
• International Society for Heart and Lung Transplantation working formulation of a standardized nomenclature for cardiac allograft vasculopathy—2010
  The Journal of Heart and Lung Transplantation, 2010